BCX4430

· BioCryst Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BCX4430, covering 2016-07-07 to 2021-07-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430 [Phase 1]